Your browser doesn't support javascript.
loading
Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults.
Zhang, Hangjie; Xu, Nani; Xu, Yu; Qin, Pan; Dai, Rongrong; Xu, Bicheng; Wang, Shenyu; Ding, Linling; Fu, Jian; Zhang, Shupeng; Hua, Qianhui; Liao, Yuting; Yang, Juan; Hu, Xiaowei; Jiang, Jianmin; Lv, Huakun.
Afiliação
  • Zhang H; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310057, China.
  • Xu N; Xihu District Center for Disease Control and Prevention, Hangzhou, 310007, China.
  • Xu Y; CanSino Biologics, Tianjin, 300457, China.
  • Qin P; Xihu District Center for Disease Control and Prevention, Hangzhou, 310007, China.
  • Dai R; School of Public Health, Hangzhou Medical College, Hangzhou, 310053, China.
  • Xu B; CanSino Biologics, Tianjin, 300457, China.
  • Wang S; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310057, China.
  • Ding L; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310057, China.
  • Fu J; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310057, China.
  • Zhang S; CanSino Biologics, Tianjin, 300457, China.
  • Hua Q; School of Medicine, Ningbo University, Ningbo, 315211, China.
  • Liao Y; School of Public Health, Xiamen University, Xiamen, 361005, China.
  • Yang J; School of Public Health, Xiamen University, Xiamen, 361005, China.
  • Hu X; Xihu District Center for Disease Control and Prevention, Hangzhou, 310007, China.
  • Jiang J; Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310057, China.
  • Lv H; School of Public Health, Hangzhou Medical College, Hangzhou, 310053, China.
Nat Commun ; 14(1): 4757, 2023 08 08.
Article em En | MEDLINE | ID: mdl-37553338
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China